Recalls / Firms / Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
5 FDA drug recalls on record — 2 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-10-21 | Class II | Opdualag | Ongoing |
| 2017-06-05 | Class I | EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company P | Terminated |
| 2012-08-29 | Class I | BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben V | Terminated |
| 2012-06-05 | Class II | Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-N | Terminated |
| 2012-06-05 | Class II | Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-N | Terminated |